Evidence map›Paper›PMID 26385921›Full record

ArticleThe Journal of biological chemistry2015

Novel β-1,4-Mannanase Belonging to a New Glycoside Hydrolase Family in Aspergillus nidulans.

Motoyuki Shimizu, Yuhei Kaneko, Saaya Ishihara, Mai Mochizuki, Kiyota Sakai, Miyuki Yamada, Shunsuke Murata, Eriko Itoh, Tatsuya Yamamoto, Yu Sugimura and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Research and application progress of microbial β-mannanases: a mini-review.World journal of microbiology & biotechnology · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Directed evolution of a β-mannanase fromBiotechnology for biofuels · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Motoyuki ShimizuFrom the Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan, moshimi@meijo-u.ac.jp.
Yuhei KanekoFrom the Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan.
Saaya IshiharaFrom the Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan.
Mai MochizukiFrom the Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan.
Kiyota SakaiFrom the Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan.
Miyuki YamadaFrom the Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan.
Shunsuke MurataFrom the Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan.
Eriko ItohGraduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8572, Japan, and.
Tatsuya YamamotoFrom the Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan.
Yu SugimuraFrom the Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan.
Tatsuya HiranoFrom the Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan.
Naoki TakayaGraduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8572, Japan, and.
Tetsuo KobayashiGraduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Aichi 464-8601, Japan.
Masashi KatoFrom the Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan.
Meijo University · JPUniversity of Tsukuba · JPNagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many filamentous fungi produce β-mannan-degrading β-1,4-mannanases that belong to the glycoside hydrolase 5 (GH5) and GH26 families. Here we identified a novel β-1,4-mannanase (Man134A) that belongs to a new glycoside hydrolase (GH) family (GH134) in Aspergillus nidulans. Blast analysis of the amino acid sequence using the NCBI protein database revealed that this enzyme had no similarity to any sequences and no putative conserved domains. Protein homologs of the enzyme were distributed to limited fungal and bacterial species. Man134A released mannobiose (M2), mannotriose (M3), and mannotetraose (M4) but not mannopentaose (M5) or higher manno-oligosaccharides when galactose-free β-mannan was the substrate from the initial stage of the reaction, suggesting that Man134A preferentially reacts with β-mannan via a unique catalytic mode. Man134A had high catalytic efficiency (kcat/Km) toward mannohexaose (M6) compared with the endo-β-1,4-mannanase Man5C and notably converted M6 to M2, M3, and M4, with M3 being the predominant reaction product. The action of Man5C toward β-mannans was synergistic. The growth phenotype of a Man134A disruptant was poor when β-mannans were the sole carbon source, indicating that Man134A is involved in β-mannan degradation in vivo. These findings indicate a hitherto undiscovered mechanism of β-mannan degradation that is enhanced by the novel β-1,4-mannanase, Man134A, when combined with other mannanolytic enzymes including various endo-β-1,4-mannanases.

Indexed as

Amino Acid SequenceAspergillus nidulansbeta-MannosidaseCatalysisFungal ProteinsMannansMannosidasesMolecular Sequence DataOligosaccharidesPhylogenySequence Analysis, Proteinbeta-Mannosidaseendo-1,4-beta-D-mannanaseFungal ProteinsMannansmannobiosemannopentaoseMannosidasesmannotetraoseOligosaccharidesAspergillusbiodegradationfungiglycoside hydrolasemicrobiologyoligosaccharidepolysaccharidetranscription regulation

Identifiers

PMID26385921
PMCPMC4646033
OpenAlexW2172322048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.